^
Association details:
| Biomarker: | EGFR-SEPTIN14 fusion |
|---|---|
| Cancer: | Non Small Cell Lung Cancer |
| Drug: | Conmana (icotinib) (EGFR inhibitor) |
| Direction: | Sensitive |
Evidence:
Source:
Title:
Prevalence of EGFR gene fusions in a large cohort of Chinese patients with non-small cell lung cancer (NSCLC).
Published date:
05/16/2018
Excerpt:
The first patient: EGFR-SEPT14 fusion driven NSCLC responding to icotinib...Thus far, after several months, the disease is stable and she is continuing treatment with icotinib...
